首页> 外文期刊>Therapeutic advances in psychopharmacology. >Successful withdrawal from high-dose benzodiazepine in a young patient through electronic monitoring of polypharmacy: a case report in an ambulatory setting
【24h】

Successful withdrawal from high-dose benzodiazepine in a young patient through electronic monitoring of polypharmacy: a case report in an ambulatory setting

机译:通过多药房电子监控成功撤出一名年轻患者的大剂量苯二氮卓类药物:非卧床病例报告

获取原文
           

摘要

Dependence on high-dose benzodiazepines (BZDs) is well known and discontinuation attempts are generally unsuccessful. A well established protocol for high-dose BZD withdrawal management is lacking. We present the case of withdrawal from high-dose lorazepam (20 mg daily) in an unemployed 35-year-old male outpatient through agonist substitution with long-acting clonazepam and electronic monitoring over 28 weeks. All medicines were repacked into weekly 7 × 4 cavity multidose punch cards with an electronic monitoring system. The prescribed daily dosages of BZDs were translated into an optimal number of daily tablets, divided into up to four units of use. Withdrawal was achieved by individual leftover of a small quantity of BZDs that was placed in a separate compartment. Feedback with visualization of intake over the past week was given during weekly psychosocial sessions. Stepwise reduction was obtained by reducing the mg content of the cavities proportionally to the leftovers, keeping the number of cavities in order to maintain regular intake behavior, and to determine the dosage decrease. At week 28, the primary objectives were achieved, that is, lorazepam reduction to 5 mg daily and cannabis abstinence. Therapy was continued using multidrug punch cards without electronic monitoring to maintain the management system. At week 48, a smaller size weekly pill organizer with detachable daily containers was dispensed. At week 68, the patient’s therapy was constant with 1.5 mg clonazepam + 5 mg lorazepam daily for anxiety symptoms and the last steps of withdrawal were started. Several key factors led to successful withdrawal from high-dose BZD in this outpatient, such as the use of weekly punch cards coupled with electronic monitoring, the patient’s empowerment over the withdrawal process, and the collaboration of several healthcare professionals. The major implication for clinical care is reduction by following the leftovers, and not a diktat from the healthcare professionals.
机译:对高剂量苯二氮卓类药物(BZDs)的依赖是众所周知的,并且停用尝试通常不会成功。缺乏用于大剂量BZD戒断管理的完善协议。我们介绍了在一名失业的35岁男性门诊患者中,通过长效氯硝西的激动剂替代和超过28周的电子监测,退出大剂量劳拉西m(每日> 20毫克)的案例。使用电子监控系统,将所有药物重新包装到每周7×4腔多剂量打孔卡中。将BZD的每日规定剂量转换为最佳每日片剂数,最多分为四个使用单位。撤离是通过将少量BZD单独留在一个单独的隔室中来实现的。在每周一次的社会心理课上,给出了过去一周摄入量可视化的反馈。通过与残留物成比例地减少型腔的mg含量,保持型腔的数量以保持规律的摄入行为并确定剂量减少来逐步减少剂量。在第28周时,达到了主要目标,即劳拉西m减少至每天5 mg和大麻禁欲。继续使用没有电子监控的多药打孔卡维持治疗系统。在第48周时,分发了一个较小尺寸的每周丸剂管理器,该容器带有可拆卸的日常容器。在第68周时,患者每天用1.5毫克氯硝西+ + 5毫克劳拉西m治疗焦虑症状的治疗是恒定的,并且开始了最后的戒断步骤。导致该门诊患者成功退出高剂量BZD的几个关键因素,例如使用每周打孔卡和电子监控,患者对退出过程的授权以及几位医疗专业人员的协作。对临床护理的主要意义是通过减少剩余物来减少,而不是从医疗保健专业人员那里获取意见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号